In this advanced approach, autologous tumour‐infiltrating lymphocytes are genetically engineered to express both dnTGF‐βRII (dominant‐negative TGFΒRII)—a truncated form lacking the intracellular domain necessary for downstream signalling—and NY‐ESO‐1 TCR.128. This evidence concerns the gene CTAG1B and neoplasm.